Roswell Park Cancer Institute | GenomeWeb

Roswell Park Cancer Institute

The Roswell Park Cancer Institute subsidiary's partnership with Cure Forward will help match patients' tumor profiles to available clinical trials. 

OmniSeq's goal is to make cancer genomic testing available to institutions, including comprehensive cancer centers, oncology practices, and community oncology groups.

NEW YORK (GenomeWeb) – Roswell Park Cancer Institute today said that the New York State Department of Health has granted approval for the institute to test cancer patients using its OmniSeq Target molecular diagnostic test.

NEW YORK (GenomeWeb) – The board of directors of New York State's development agency has approved $105 million in funding to establish the NYS Genomic Medicine and Big Data Center (GMBDC), a genomics data partnership that will connect institutions in Buffalo with the New York Genome Center, Gov.

NEW YORK (GenomeWeb News) – Life Technologies today announced the Ion AmpliSeq Exome Certified Service Provider program and its first members.

NEW YORK (GenomeWeb News) – Roswell Park Cancer Institute is investing $18.5 million to fund the launch of a new Center for Personalized Medicine (CPM) at its campus in Buffalo, according to the office of NY Governor Andrew Cuomo.

New York State plans to fund a two-year, $5.1 million sequencing pilot project of 1,000 residents in Western New York under its Regional Economic Development Council Initiative.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – A Roswell Park Cancer Institute researcher will use a $100,000 award to develop a blood-based test for diagnosing lung cancer.

Exiqon said today that it has signed a "center of excellence" agreement with the Roswell Park Cancer Institute.
Under the agreement, Buffalo, NY-based RPCI will provide real-time PCR services using Exiqon's Mircury LNA Universal RT microRNA PCR products.


In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.